bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2023,
Номер
unknown
Опубликована: Сен. 1, 2023
Abstract
EG.5.1
is
a
subvariant
of
the
SARS-CoV-2
Omicron
XBB
variant
that
rapidly
increasing
in
prevalence
worldwide.
has
additional
substitutions
its
spike
protein
(namely,
Q52H
and
F456L)
compared
with
XBB.1.5.
However,
pathogenicity,
transmissibility,
immune
evasion
properties
clinical
isolates
are
largely
unknown.
In
this
study,
we
used
wild-type
Syrian
hamsters
to
investigate
replicative
ability,
transmissibility
isolate.
Our
data
show
there
no
obvious
differences
growth
ability
pathogenicity
between
XBB.1.5,
both
XBB.1.5
attenuated
Delta
We
also
found
transmitted
more
efficiently
addition,
unlike
detected
virus
lungs
four
six
exposed
hamsters,
suggesting
tropism
different
from
after
airborne
transmission.
Finally,
assessed
neutralizing
plasma
convalescent
individuals
activity
against
was
slightly,
but
significantly,
lower
than
or
XBB.1.9.2.
This
suggests
effectively
evades
humoral
immunity
amino
acid
S
XBB.1.9.2
(i.e.,
Q52H,
R158G,
alter
antigenicity
EG.5.1.
suggest
increased
altered
may
be
driving
over
human
population.
Nature Communications,
Год журнала:
2024,
Номер
15(1)
Опубликована: Фев. 8, 2024
Abstract
Circulation
of
SARS-CoV-2
Omicron
XBB
has
resulted
in
the
emergence
XBB.1.5,
a
new
Variant
Interest.
Our
phylogenetic
analysis
suggests
that
XBB.1.5
evolved
from
XBB.1
by
acquiring
S486P
spike
(S)
mutation,
subsequent
to
acquisition
nonsense
mutation
ORF8.
Neutralization
assays
showed
similar
abilities
immune
escape
between
and
XBB.1.
We
determine
structural
basis
for
interaction
human
ACE2
S
protein
showing
overall
structures
proteins
XBB.1.5.
provide
intrinsic
pathogenicity
hamsters.
Importantly,
we
find
ORF8
impairment
MHC
suppression.
In
vivo
experiments
using
recombinant
viruses
reveal
mutations
are
involved
with
reduced
virulence
Together,
our
study
identifies
two
viral
functions
defined
difference
Cell Reports,
Год журнала:
2023,
Номер
42(12), С. 113580 - 113580
Опубликована: Дек. 1, 2023
EG.5.1
is
a
subvariant
of
the
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
Omicron
XBB
variant
that
rapidly
increasing
in
prevalence
worldwide.
However,
pathogenicity,
transmissibility,
and
immune
evasion
properties
isolates
are
largely
unknown.
Here,
we
show
there
no
obvious
differences
growth
ability
pathogenicity
between
XBB.1.5
hamsters.
We
also
demonstrate
that,
like
XBB.1.5,
transmitted
more
efficiently
hamsters
compared
to
its
predecessor,
BA.2.
In
contrast,
unlike
detect
lungs
four
six
exposed
hamsters,
suggesting
virus
different
from
those
XBB.1.5.
Finally,
find
neutralizing
activity
plasma
convalescent
individuals
against
was
slightly,
but
significantly,
lower
than
or
XBB.1.9.2.
Our
data
suggest
after
transmission
altered
antigenicity
may
be
driving
over
humans.
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2023,
Номер
unknown
Опубликована: Авг. 17, 2023
Summary
Circulation
of
SARS-CoV-2
Omicron
XBB
has
resulted
in
the
emergence
XBB.1.5,
a
new
Variant
Interest.
Our
phylogenetic
analysis
suggests
that
XBB.1.5
evolved
from
XBB.1
by
acquiring
F486P
spike
(S)
mutation,
subsequent
to
acquisition
nonsense
mutation
ORF8.
Neutralization
assays
showed
similar
abilities
immune
escape
between
and
XBB.1.
We
determined
structural
basis
for
interaction
human
ACE2
S
protein
showing
overall
structures
proteins
XBB.1.5.
The
intrinsic
pathogenicity
hamsters
is
lower
than
Importantly,
we
found
ORF8
impairment
MHC
expression.
In
vivo
experiments
using
recombinant
viruses
revealed
mutations
are
involved
with
reduced
virulence
Together,
these
data
suggest
could
enhance
spreading
humans.
Frontiers in Immunology,
Год журнала:
2025,
Номер
16
Опубликована: Янв. 28, 2025
In
this
article
we
discuss
characteristics
of
fusion
protein-based
SARS-CoV-2
vaccines.
We
focus
on
recombinant
vaccine
antigens
comprising
proteins
consisting
combinations
SARS-CoV-2-derived
or
peptides
antigens/peptides
with
SARS-CoV-2-unrelated
proteins/peptides.
These
are
made
to
increase
the
immunogenicity
and/or
enable
special
targeting
immune
system.
The
approach
is
exemplified
solely
in
a
proof
concept
study
by
using
W-PreS-O,
chimeric
based
single
protein
(W-PreS-O),
combining
RBDs
from
Wuhan
hu-1
wild-type
and
Omicron
BA.1
hepatitis
B
virus
(HBV)-derived
PreS
surface
antigen
adsorbed
aluminum
hydroxide.
W-PreS-O
was
evaluated
Syrian
hamsters
which
were
immunized
three
times
at
three-week
intervals
hydroxide
(placebo)
before
they
infected
BA.1.
Neutralizing
antibody
(nAB)
titers,
weight,
lung
symptoms,
viral
loads,
as
measured
RT-PCR
upper
lower
respiratory
tracts,
determined.
addition,
infectious
titers
lungs
plaque-forming
assay.
found
that
W-PreS-O-vaccinated
developed
robust
nABs
against
BA.1,
showed
almost
no
development
pneumonia,
had
significantly
reduced
lungs.
Importantly,
loads
nasal
cavities
close
above
PCR
cycle
threshold
considered
be
non-infectious.
data
our
proof-of-concept
provides
compelling
evidence
has
protective
effect
hamster
vivo
infection
model
thus
support
promising
results
obtained
also
for
other
Journal of Virology,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 12, 2025
ABSTRACT
In
general,
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
replicates
well
at
37°C,
which
is
the
temperature
of
human
lower
tract,
but
it
poorly
30°C‒32°C,
upper
tract.
The
replication
efficiency
SARS-CoV-2
in
tract
may
directly
affect
its
transmissibility.
this
study,
an
XBB.1.5
isolate
showed
superior
replicative
ability
32°C
and
30°C,
whereas
most
other
Omicron
sub-variant
isolates
limited
growth.
Deep
sequencing
analysis
demonstrated
that
frequencies
viruses
possessing
NSP6-S163P
NSP13-P238S
substitutions
increased
to
more
than
97%
during
propagation
did
not
reach
55%
37°C.
Reverse
genetics
revealed
these
contributed
virus
growth
vitro
low
temperatures
by
improving
genome
replication.
Mutant
both
slightly
higher
titers
hamsters
compared
parental
virus;
however,
transmissibility
between
was
similar
for
mutant
viruses.
Taken
together,
our
findings
indicate
contribute
hamsters.
IMPORTANCE
Severe
efficiently
However,
airway
30°C–32°C.
Therefore,
could
influence
we
assessed
sub-variants
found
ability.
By
deep
reverse
genetics,
amino
acid
changes
NSP6
NSP13
low-temperature
growth;
improved
RNA
polymerase
activity
enhanced
Although
alone
drastically
transmissibility,
combination
with
substitutions,
they
humans.
Furthermore,
since
enhance
cultured
cells,
be
used
improve
production
inactivated
or
live
attenuated
vaccine
virus.
Abstract
Since
the
emergence
of
SARS-CoV-2
in
humans,
novel
variants
have
evolved
to
become
dominant
circulating
lineages.
These
include
D614G
(B.1
lineage),
Alpha
(B.1.1.7),
Gamma
(P.1),
Delta
(B.1.617.2),
and
Omicron
BA.1
(B.1.1.529)
BA.2
(B.1.1.529.2)
viruses.
Here,
we
compared
viral
replication,
pathogenesis,
transmissibility
these
variants.
Replication
kinetics
innate
immune
response
against
viruses
were
tested
ex
vivo
human
nasal
epithelial
cells
(HNEC)
induced
pluripotent
stem
cell-derived
lung
organoids
(IPSC-LOs),
golden
hamster
model
was
employed
test
pathogenicity
potential
for
transmission
by
respiratory
route.
Delta,
BA.1,
replicated
more
efficiently,
outcompeted
D614G,
Alpha,
an
HNEC
competition
assay.
viruses,
however,
poorly
IPSC-LOs
other
Moreover,
virus
infection
significantly
increased
secretion
IFN-λ1,
IFN-λ2,
IFN-λ3,
IL-6,
IL-1RA
HNECs
relative
infection,
but
not
IPSC-LOs.
The
less
effectively
lungs
variants;
while
reached
titers
comparable
it
caused
greater
pathology.
Lastly,
transmitted
efficiently
route
efficiently.
findings
demonstrate
ongoing
utility
experimental
risk
assessment
as
continue
evolve.
The
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
Omicron
variant
exhibits
high
transmissibility
with
a
strong
immune
escape
ability
and
causes
frequent
large-scale
global
infections
by
producing
predominant
subvariants.
Here,
using
human
upper/lower
airway
intestinal
cells,
we
examined
the
previously
dominant
BA.1-BA.5
BA.2.75
subvariants,
together
recently
emerged
XBB/BQ
lineages,
in
comparison
to
former
Delta
variant.
We
observed
tendency
for
each
virus
demonstrate
higher
growth
capability
than
Unlike
bronchial
nasal
epithelial
cells
accommodated
efficient
entry
of
certain
similar
In
contrast
Delta's
reliance
on
cell-surface
transmembrane
protease
serine
2,
all
tested
variants
depended
endosomal
cathepsin
L.
Moreover,
S1/S2
cleavage
early
spikes
was
less
efficient,
whereas
recent
viruses
exhibit
improved
efficacy.
Our
results
show
that
progressively
adapts
through
continuous
endosome-mediated
host
cell
entry.IMPORTANCESARS-CoV-2,
causative
agent
disease
2019,
has
evolved
into
number
variants/subvariants,
which
have
generated
multiple
waves
infection.
order
monitor/predict
virological
features
emerging
determine
appropriate
strategies
anti-viral
development,
understanding
conserved
or
altered
evolving
SARS-CoV-2
is
important.
this
study,
addressed
subvariants
demonstrated
gradual
adaptation
cells.
route,
from
variant,
among
Collectively,
study
revealed
both
changing
maintained
during
evolution.
Proceedings of the National Academy of Sciences,
Год журнала:
2023,
Номер
120(45)
Опубликована: Окт. 30, 2023
The
ongoing
SARS-CoV-2
epidemic
was
marked
by
the
repeated
emergence
and
replacement
of
"variants"
with
genetic
phenotypic
distance
from
ancestral
strains,
most
recent
examples
being
viruses
Omicron
lineage.
Here,
we
describe
a
hamster
direct
contact
exposure
challenge
model
to
assess
protection
against
reinfection
conferred
either
vaccination
or
prior
infection.
We
found
that
two
doses
self-amplifying
RNA
vaccine
based
on
Spike
ameliorated
weight
loss
following
Delta
infection
decreased
viral
loads
but
had
minimal
effect
BA.1
Prior
followed
breakthrough
infections
led
high
degree
cross-reactivity
all
tested
variants,
suggesting
antigenically
distinct
Spikes,
via
and/or
drives
cross-reactive
immune
response.
Alpha
variant
partially
protective
infection,
whereas
animals
previously
infected
exposed
became
reinfected,
although
they
shed
less
virus
than
BA.1-infected
naive
hamsters.
Hamsters
reinfected
after
emitted
infectious
into
air,
indicating
could
be
responsible
for
onwards
airborne
transmission.
further
whether
protected
later
sublineages
BA.2,
BA.4,
BA.5.
BA.2
not
Delta,
BA.5
reinfection.
These
findings
suggest
cohorts
whose
only
experience
COVID-19
is
may
vulnerable
future
circulation
reemerged
Delta-like
derivatives,
as
well
emerging
sublineages.